Blum, Claudine A.
Roethlisberger, Eva A.
Cesana-Nigro, Nicole
Winzeler, Bettina
Rodondi, Nicolas
Blum, Manuel R.
Briel, Matthias
Mueller, Beat
Christ-Crain, Mirjam
Schuetz, Philipp
Funding for this research was provided by:
University of Basel
Article History
Received: 25 June 2023
Accepted: 28 November 2023
First Online: 11 December 2023
Declarations
:
: The conduct of the trial adhered to the declaration of Helsinki and Good Clinical Practice Guidelines, and the ethical committees of all participating hospitals (ethics committees: Ethikkommission beider Basel EKBB (Reference Number 370/08), Ethikkommission der Kantone Aargau und Solothurn (Reference Number 2011/031), commission d’ethique Lausanne (Reference Number 116/10) and Ethikkommission Bern (Reference Number 193/11)), as well as the Swiss Agency for Therapeutic Products (SWISSMEDIC (Reference Number 2009DR3227)) approved the study protocol before patient recruitment. All patients provided written informed consent [CitationRef removed].This trial was registered with ClinicalTrials. gov, number NCT00973154 before the recruitment of the first patient. First posted: September 9, 2009. Last update posted: April 21, 2015 [CitationRef removed].
: Not applicable.
: The authors declare no competing interests.